Key result
Tyramine reaction during MAOI therapy triggers fully reversible reverse takotsubo cardiomyopathy and hypertensive crisis.
Why the study?
Takotsubo cardiomyopathy is typically precipitated by emotional stress, but the exact pathogenesis remains unclear.
This case report provides the first evidence of reverse takotsubo cardiomyopathy precipitated by a tyramine reaction in the setting of monoamine oxidase inhibitor use.
Answers are grounded in this paper and cite their sources.
Reinforces tyramine avoidance in MAOI patients; first evidence extends reverse Takotsubo triggers and remains hypothesis-generating.
Background Reverse takotsubo cardiomyopathy is a variant of takotsubo cardiomyopathy (TC) where the basal and midventricular segments of the left ventricle are akinetic. TC is typically precipitated by emotional stress; however, the exact pathogenesis of the disease remains unclear. Case Summary A 25‐year‐old woman, without any risk factors, presented with a hypertensive crisis and reverse takotsubo cardiomyopathy after a tyramine reaction. The symptoms and cardiomyopathy resolved completely. Discussion This report is the first to describe a case of takotsubo cardiomyopathy precipitated by a tyramine reaction in the setting of a monoamine oxidase inhibitor. This paper will include a pharmacological and pathophysiological review of the described case.
No takes yet. Share an insight, caveat, or question.
Holley et al. (2026) studied this question. A tyramine reaction in the setting of monoamine oxidase inhibitor use induced a fully reversible case of reverse takotsubo cardiomyopathy and hypertensive crisis in a 25-year-old woman.
Synapse has enriched 10 related papers. Consider them for comparative context: